Mark Findlay

Vice President, Cardiovascular, Renal and Metabolic & Established Brands Business Units

All Sessions by Mark Findlay

Printer Friendly See Full Agenda

Day 1: Jan 26, 2021

11:05 am

11:05 am


The New Normal for Pharma Marketing: Comprehending the Impact of COVID and What’s Next

The pandemic has had a massive impact on everyone and the pharma industry is looking for answers. When is COVID-19 going away? What does the future pharma organization look like? How do you leverage technology to make sales and marketing more effective? Gain the expert insights you need to move your organization from “stand by” to “new normal” including:

  • Analyzing the rise of telemedicine and drive in medical labs and other fundamental changes to HCPs’ practices
  • Evaluating the changing roles of the pharmacists and nurses under COVID-19
  • Anticipating diagnosis reckonings post-COVID-19: which pharmaceutical products will be more in demand in the coming year
  • Assessing supply chain issues: what is the impact of COVID-19 on the manufacturing of products, equipment and medical supplies?

Amplify your understanding of the effects of COVID-19 on pharma to help you structure your organization for success.

Day 2: Jan 27, 2021